Clinical features and prognosis of severe legionnaires’ disease requiring intensive care unit admission: a multicentric retrospective cohort study

Anaïs Dartevel(Centre Hospitalier Universitaire de Grenoble), Nicolas Terzi(Inserm), Cédric Daubin(Centre Hospitalier Universitaire de Caen Normandie), Guillaume Thiéry(Université Claude Bernard Lyon 1), Carole Schwebel(Centre Hospitalier Universitaire de Grenoble), Vincent Peigne(Centre Hospitalier Métropole Savoie), Kada Klouche(Centre National de la Recherche Scientifique), Alexandre Lautrette(Centre Hospitalier Universitaire de Clermont-Ferrand), Bertrand Sauneuf(Centre Hospitalier Public du Cotentin), Michel Ramakers, Nicholas Sedillot, Jean-Philippe Rigaud(CHU Dijon Bourgogne), Louis-Marie Galerneau(Université Grenoble Alpes), Julien Poissy(Centre National de la Recherche Scientifique), Stéphan Ehrmann(Inserm)
Pneumonia
August 24, 2025
10.1186/s41479-025-00173-z
Cited by 2

Related Papers

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
|JAMA|2020|518
Hydrocortisone in Severe Community-Acquired Pneumonia
|New England Journal of Medicine|2023|438
Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial
|The Lancet|2018|395
Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at High Risk of Extubation Failure
|JAMA|2019|353
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344